LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania

As part of IASLC’s Lung Cancer Considered world language series, Dr. Mihaela Aldea moderates a discussion in Romanian with Dr. Miruna Grecea and Dr. Andrei Ungureanu about the diagnosis, molecular testing, and treatment strategies for a patient with locally advanced, unresectable EGFR-mutant non-small cell lung cancer in Romania. The episode explores multidisciplinary approaches, the use of osimertinib as consolidation therapy post-chemoradiotherapy based on the LAURA trial, and considerations for follow-up and disease progression.